How much does Harvoni (Ledipasvir and Sofosbuvir Tablets) Cost& price without insurance in China?
Harvoni® is the commercial brand name of Ledipasvir and Sofosbuvir Tablets, an oral fixed-dose combination anti-HCV drug developed by Gilead Sciences. Ledipasvir inhibits HCV NS5A protein while sofosbuvir blocks viral NS5B polymerase, jointly suppressing hepatitis C virus replication.
Main Indications
Treatment of chronic hepatitis C virus infection in adults and adolescents aged from 12 to less than 18 years old.
Common Side Effects
Common mild adverse reactions: Headache, fatigue, insomnia and nausea.
Laboratory abnormalities: Rare transient mild elevation of liver enzymes.
Severe but manageable risks: Severe bradycardia when combined with amiodarone and hypersensitivity reactions.
Approval Status in China
Harvoni® (Ledipasvir 90mg+Sofosbuvir 400mg per tablet, domestic Chinese brand name: Xiafanning) was officially approved for marketing in China in 2018. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Harvoni (Ledipasvir and Sofosbuvir Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
